Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin

Clinical Toxicology

Volumn 45, Issue 5, 2007, Pages 512-515

  Kuca, Kamil ^a,b   Cabal, Jiri ^a   Jun, Daniel ^a   Hrabinova, Martina ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Cholinesterase; Cyclosarin; Nerve agent; Oxime; Reactivators

Indexed keywords

1 (3 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 (4 CARBAMOYLPYRIDINIO) 4 (2 HYDROXYIMINOMETHYLPYRIDINIO) 2 BUTENE DIBROMIDE; CHOLINESTERASE; CHOLINESTERASE REACTIVATOR; CYCLOSARIN; METHOXIME; PRALIDOXIME; TRIMEDOXIME; UNCLASSIFIED DRUG;

AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REACTIVATION; HUMAN; HUMAN TISSUE; MALE;

AGED; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; CHOLINESTERASES; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; OXIMES; PRALIDOXIME COMPOUNDS; PYRIDINIUM COMPOUNDS; TRIMEDOXIME;

EID: 34248574305     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701354234     Document Type: Article

References (29)

1. Bajgar J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38:151-216.
2. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 2002; 40:803-816.
3. Kuca K, Jun D, Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 2006; 6:269-277.
4. Kim TH, Kuca K, Jun D, Jung YS. Design and synthesis of new bispyridinium oximes as cyclosarin-inhibited acetylcholinesterase reactivators. Bioorg Med Chem Lett 2005; 15:2914-2917.
5. Pang YP, Kollmeyer TM, Hong F, Lee JC, Hammond PI, Haugabouk SP, Brimijoin S. Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem Biol 2003; 10:491-502.
6. Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 2005; 20:409-415.
7. Picha J, Kuca K, Kivala M, Kohout M, Cabal J, Liska F. New group of monoquaternary reactivators of the acetylcholinesterase inhibited by nerve agents. J Enzyme Inhib Med Chem 2005; 20:233-237.
8. Kassa J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol 1999; 18:560-5.
9. Worek F, Backer M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 1997; 16:466-72.
10. Krejcova G, Kuca K, Sevelova L. Cyclosarin - current position of an organophosphate nerve agent. Def Sci J 2005; 55:105-115.
11. Kassa J, Cabal J. A comparison of the efficacy of acetylcholine reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 1999; 84:41-46.
12. Kassa J, Fusek J. The influence of oxime selection on the efficacy of antidotal treatment of soman-poisoned rats. Acta Medica (Hradec Kralove) 2002; 45:19-27.
13. Cabal J, Kuca K, Kassa J. Specification of the structure of oximes able to reactivate tabun inhibited acetylcholinesterase. Bas Clin Pharmacol Toxicol 2004; 95:81-86.
14. Balali-Mood M, Shariat M. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. J Physiology (Paris) 1998; 92:375-8.
15. Jun D, Kuca K, Hronek M, Opletal L. Effect of some acetylcholinesterase reactivators on human platelet aggregation in vitro. J Appl Toxicol 2006; 26:262-8.
16. Bismuth C, Ins RH, Marrs TC. Efficacy, toxicity and clinical use of oxime in anticholinesterase poisoning. In: Ballantyne B, Marrs TC, Aldrige WN, eds., Clinical and experimental toxicology of organophosphates and carbamates. Oxford, England: Butterworth-Heinmann Ltd., 1992:555-577.
17. Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Biorg Med Chem Lett 2006; 16:622-627.
18. Kuca K, Patocka J. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J Enzyme Inhib Med Chem 2004; 19: 39-43.
19. Sevelova L, Kuca K, Krejcova G. Antidotal treatment of GF-agent intoxication in mice with new bispyridinium oximes. Toxicology 2005; 207:1-6.
20. Krejcova-Kunesova G, Bartosova L, Kuca K. Signs of cyclosar-ininduced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators. Toxicology 2005; 216:32-40.
21. Bartosova L, Kuca K, Jun D, Kunesova G. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning - in vitro and in vivo testing. Inter J Toxicol 2005; 24:399-402.
22. Calic M, Lucic Vrdoljak A, Radic B, Jelic D, Jun D, Kuca K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006; 219:85-96.
23. Clement JG, Erhardt N. In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human. Arch Toxicol 1994; 68:648-655.
24. Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002; 76:523-529.
25. Kuca K, Cabal J, Kassa J. In vitro reactivation of sarin-inhibited brain acetylcholinesterase from various species by various oximes. J Enzyme Inhib Med Chem 2005; 20:227-232.
26. Petroianu GA, Hasan MY, Nurulain SM, Arafat K, Sha Ullah M, Naseer O: Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. J Appl Toxicol 2005; 25:68-73.
27. Kuca K, Kassa J. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium) butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem 2003; 18:529-535.
28. Kuca K, Cabal J, Jun D, Kassa J, Bartosova L, Kuneova G, Dohnal V. Development of new acetylcholinesterase reactivators - antidotes used for treatment of nerve agent poisonings. Biomed Pap 2005; 149:429-431.
29. Worek F, Eyer P, Szinicz L. Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch Toxicol 1998; 72:580-587.